Association of Obesity and Negative Acid-Fast Bacilli Finding Among Pulmonary Tuberculosis Patients with Type 2 Diabetes Mellitus
non-diabetes mellitus population. However, it’s effect on PTB in type 2
diabetes mellitus (T2DM) patient is unclear. The study aims to determine
the association between obesity and PTB in patient with T2DM. A crosssectional study was held in in-patient, The Department of Internal Medicine, Fatmawati General Hospital from January 2015 to December 2017.
This study includes patient with T2DM who had been diagnosed with PTB
and age > 18 years old. In this study negative Acid-fast-bacilli (AFB)
founding defined as patient’s sputum is negative by smear microscopy,
while obesity define as body mass index > 24.9 kg/m2. From 363 PTB
patient with T2DM, 22.59% were obese. Results showed that prevalence
of negative AFB founding in PTB patients with T2DM was 81.82% and it
was solely associated with obesity (p:0.002, OR=6.36, 95%CI 1.9-21). Obese
patients were likely to have negative AFB founding. It suggested that
diagnosing PTB in patient with T2DM and obese can’t be solely based on
WHO. Guideline on Management of Drug Resistance-TB.; 2018. doi:10.1001/jama.2014.11450
Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Tubercle and Lung Disease Incidence of pulmonary tuberculosis among diabetics. 1995;(September 1994):529-533.
K. P. AH, Ayoob MA. Impact of diabetes mellitus on clinical presentation and treatment response of smear positive pulmonary tuberculosis patients. Int J Res Med Sci. 2017;5(4):1245. doi:10.18203/2320-6012.ijrms20170977
WHO. Tuberculosis Facts- Tuberculosis and Diabetes. 2016. www.who.int/tb.
Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One. 2017;12(11):1-26. doi:10.1371/journal.pone.0187967
Lin HH, Wu CY, Wang CH, et al. Association of obesity, diabetes, and risk of tuberculosis: Two population-based cohorts. Clin Infect Dis. 2018;66(5):699-705. doi:10.1093/cid/cix852
Leung G, Law WS, Tam CM, Chan CK, Chang KC. Lower Risk of Tuberculosis in Obesity. 2015;167:1297-1304.
Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. 2010;(October 2009):149-155. doi:10.1093/ije/dyp308
Kim SJ, Ye S, Ha E, Chun EM. Association of body mass index with incident tuberculosis in Korea. PLoS One. 2018;13(4):1-12. doi:10.1371/journal.pone.0195104
O’Rourke RW, Kay T, Scholz MH, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg. 2005;15(10):1463-1468. doi:10.1381/096089205774859308
Lai Y. Accepted Article Preview : Published ahead of advance online publication. 2017;(October 2016). doi:10.1038/ijo.2017.64
Farooqi IS, Depaoli AM, Rahilly SO, et al. Beneficial effects of leptin on obesity. J Clin Invest. 2002;110(8):1093-1103. doi:10.1172/JCI200215693.Introduction
Umakanth M, Rishikesavan S. Prevalence of diabetes mellitus among tuberculosis patient in Batticaloa district , Sri Lanka. 2017;2(2):21-23. doi:10.5588/pha.13.0024.5.
Mexitalia M, Dewi YO, Pramono A, Anam MS. Effect of tuberculosis treatment on leptin levels, weight gain, and percentage body fat in Indonesian children. Korean J Pediatr. 2017;60(4):118-123. doi:10.3345/kjp.2017.60.4.118
Çakır B, Yönem A, Güler S, et al. Relation of Leptin and Tumor Necrosis Factor α to Body Weight Changes in Patients with Pulmonary Tuberculosis. Horm Res Paediatr. 1999;52(6):279-283. doi:10.1159/000023495
Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33(1):35-45. doi:10.1016/j.mam.2011.10.012
- There are currently no refbacks.